Tapewire

Nasdaq · USD

INCY

INCYTE CORP

Export transactions ↓
Tapewire entity
3182
SEC CIK
0000879169
Parsed reports
950

Last 12 months

Inside the activity.

0 purchase rows · 46 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202507
Dec 202509
Jan 202602
Feb 202601
Mar 202601
Apr 202601
May 202602
Jun 202601
Jul 2026015
Aug 202605
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 16, 2025 Filed Sep 18, 2025 20:06 UTC
Denton Sheila A.EVP & General Counsel
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 278 $0.00 Strike: $64.25 $0.00
Disclosure

SEC source: 0001995298-25-000006 · wk-form4_1758225978.xml · derivative · entry 3

Denton Sheila A. · CIK 0001995298 · EVP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,438

Underlying: Common Stock · 278 shares

Expires 2034-07-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The July 15, 2024 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.

Read SEC document
September 16, 2025 Filed Sep 18, 2025 20:06 UTC
Denton Sheila A.EVP & General Counsel
SaleCommon Stock 278 $83.15 $23,115.70
Disclosure

SEC source: 0001995298-25-000006 · wk-form4_1758225978.xml · nonDerivative · entry 2

Denton Sheila A. · CIK 0001995298 · EVP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,200

F1 · balance_after: This includes an aggregate of 32,544 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance units that have not vested.

Read SEC document
September 16, 2025 Filed Sep 18, 2025 20:06 UTC
Denton Sheila A.EVP & General Counsel
Exercise / conversionCommon Stock 278 $64.25 $17,861.50
Disclosure

SEC source: 0001995298-25-000006 · wk-form4_1758225978.xml · nonDerivative · entry 1

Denton Sheila A. · CIK 0001995298 · EVP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,478

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 02, 2025 Filed Sep 4, 2025 20:04 UTC
Denton Sheila A.EVP & General Counsel
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 598 $0.00 Strike: $58.06 $0.00
Disclosure

SEC source: 0001995298-25-000004 · wk-form4_1757016265.xml · derivative · entry 3

Denton Sheila A. · CIK 0001995298 · EVP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,962

Underlying: Common Stock · 598 shares

Expires 2033-10-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Beginning October 2, 2023, options become exercisable in 37 installments, with the first 25% vesting on October 2, 2024 and the remainder vesting monthly over three years.

Read SEC document
September 02, 2025 Filed Sep 4, 2025 20:04 UTC
Denton Sheila A.EVP & General Counsel
SaleCommon Stock 598 $84.97 $50,812.06
Disclosure

SEC source: 0001995298-25-000004 · wk-form4_1757016265.xml · nonDerivative · entry 2

Denton Sheila A. · CIK 0001995298 · EVP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,200

F1 · balance_after: This includes an aggregate of 32,544 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance units that have not vested.

Read SEC document
September 02, 2025 Filed Sep 4, 2025 20:04 UTC
Denton Sheila A.EVP & General Counsel
Exercise / conversionCommon Stock 598 $58.06 $34,719.88
Disclosure

SEC source: 0001995298-25-000004 · wk-form4_1757016265.xml · nonDerivative · entry 1

Denton Sheila A. · CIK 0001995298 · EVP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,798

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 25, 2025 Filed Aug 27, 2025 20:43 UTC
Basi Ramitpal KEVP, Human Resources
GrantEmployee Stock Option (right to buy) · Derivative 29,230 $0.00 Strike: $84.76 $0.00
Disclosure

SEC source: 0002083591-25-000004 · wk-form4_1756327397.xml · derivative · entry 3

Basi Ramitpal K · CIK 0002083591 · EVP, Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,230

Underlying: Common Stock · 29,230 shares

Expires 2035-08-24

F4 · derivative.exercise_date: The August 25, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.

Read SEC document
August 25, 2025 Filed Aug 27, 2025 20:43 UTC
Basi Ramitpal KEVP, Human Resources
GrantPerformance Shares · Derivative 16,265 $0.00 $0.00
Disclosure

SEC source: 0002083591-25-000004 · wk-form4_1756327397.xml · derivative · entry 2

Basi Ramitpal K · CIK 0002083591 · EVP, Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,265

Underlying: Common Stock · 16,265 shares

Expires 2028-08-25

F3 · derivative.exercise_price: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.

F3 · derivative.exercise_date: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.

Read SEC document
August 25, 2025 Filed Aug 27, 2025 20:43 UTC
Basi Ramitpal KEVP, Human Resources
GrantCommon Stock 6,506 $0.00 $0.00
Disclosure

SEC source: 0002083591-25-000004 · wk-form4_1756327397.xml · nonDerivative · entry 1

Basi Ramitpal K · CIK 0002083591 · EVP, Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,506

F1 · shares: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis.

F2 · balance_after: Includes the August 25, 2025 aggregate grant of 6,506 shares of common stock.

Read SEC document
August 15, 2025 Filed Aug 19, 2025 20:13 UTC
Denton Sheila A.EVP & General Counsel
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 277 $0.00 Strike: $64.25 $0.00
Disclosure

SEC source: 0000879169-25-000109 · wk-form4_1755634387.xml · derivative · entry 3

Denton Sheila A. · CIK 0001995298 · EVP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,716

Underlying: Common Stock · 277 shares

Expires 2034-07-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The July 15, 2024 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.

Read SEC document
August 15, 2025 Filed Aug 19, 2025 20:13 UTC
Denton Sheila A.EVP & General Counsel
SaleCommon Stock 277 $86.81 $24,046.37
Disclosure

SEC source: 0000879169-25-000109 · wk-form4_1755634387.xml · nonDerivative · entry 2

Denton Sheila A. · CIK 0001995298 · EVP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,200

F1 · balance_after: This includes an aggregate of 32,544 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance units that have not vested.

Read SEC document
August 15, 2025 Filed Aug 19, 2025 20:13 UTC
Denton Sheila A.EVP & General Counsel
Exercise / conversionCommon Stock 277 $64.25 $17,797.25
Disclosure

SEC source: 0000879169-25-000109 · wk-form4_1755634387.xml · nonDerivative · entry 1

Denton Sheila A. · CIK 0001995298 · EVP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,477

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 04, 2025 Filed Aug 6, 2025 20:03 UTC
Denton Sheila A.EVP & General Counsel
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 598 $0.00 Strike: $58.06 $0.00
Disclosure

SEC source: 0000879169-25-000106 · wk-form4_1754510586.xml · derivative · entry 3

Denton Sheila A. · CIK 0001995298 · EVP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,560

Underlying: Common Stock · 598 shares

Expires 2033-10-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Beginning October 2, 2023, options become exercisable in 37 installments, with the first 25% vesting on October 2, 2024 and the remainder vesting monthly over three years.

Read SEC document
August 04, 2025 Filed Aug 6, 2025 20:03 UTC
Denton Sheila A.EVP & General Counsel
SaleCommon Stock 598 $75.77 $45,310.46
Disclosure

SEC source: 0000879169-25-000106 · wk-form4_1754510586.xml · nonDerivative · entry 2

Denton Sheila A. · CIK 0001995298 · EVP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,200

F1 · balance_after: This includes an aggregate of 32,544 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance units that have not vested.

Read SEC document
August 04, 2025 Filed Aug 6, 2025 20:03 UTC
Denton Sheila A.EVP & General Counsel
Exercise / conversionCommon Stock 598 $58.06 $34,719.88
Disclosure

SEC source: 0000879169-25-000106 · wk-form4_1754510586.xml · nonDerivative · entry 1

Denton Sheila A. · CIK 0001995298 · EVP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,798

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 21, 2025 Filed Jul 23, 2025 19:56 UTC
Stein Steven HEVP & Chief Medical Officer
SaleCommon Stock 3,706 $67.94 $251,785.64
Disclosure

SEC source: 0000879169-25-000095 · wk-form4_1753300580.xml · nonDerivative · entry 1

Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 102,886

F1 · balance_after: This includes an aggregate of 100,327 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested.

Read SEC document
July 16, 2025 Filed Jul 17, 2025 20:06 UTC
Flannelly Barry PEVP & General Manager US
SaleCommon Stock 1,340 $68.36 $91,602.40
Disclosure

SEC source: 0000879169-25-000093 · wk-form4_1752782756.xml · nonDerivative · entry 1

Flannelly Barry P · CIK 0001615842 · EVP & General Manager US

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 35,149

F1 · balance_after: This includes an aggregate of 35,136 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested.

Read SEC document
July 16, 2025 Filed Jul 17, 2025 20:05 UTC
Iyengar Vijay KEVP, GMAPPS
SaleCommon Stock 983 $68.36 $67,197.88
Disclosure

SEC source: 0000879169-25-000092 · wk-form4_1752782723.xml · nonDerivative · entry 1

Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,540

F1 · balance_after: This includes an aggregate of 37,752 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.

Read SEC document
July 16, 2025 Filed Jul 17, 2025 20:04 UTC
Denton Sheila A.EVP & General Counsel
SaleCommon Stock 785 $68.36 $53,662.60
Disclosure

SEC source: 0000879169-25-000091 · wk-form4_1752782690.xml · nonDerivative · entry 5

Denton Sheila A. · CIK 0001995298 · EVP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,200

F3 · balance_after: Including the July 15, 2025 grant, this includes an aggregate of 32,544 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance units that have not vested.

Read SEC document
July 15, 2025 Filed Jul 16, 2025 20:05 UTC
CAGNONI PABLO JPresident, R&D
GrantEmployee Stock Option (right to buy) · Derivative 39,471 $0.00 Strike: $68.25 $0.00
Disclosure

SEC source: 0000879169-25-000086 · wk-form4_1752696353.xml · derivative · entry 5

CAGNONI PABLO J · CIK 0001205703 · President, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,471

Underlying: Common Stock · 39,471 shares

Expires 2035-07-14

F5 · derivative.exercise_date: The July 15, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.

Read SEC document
July 15, 2025 Filed Jul 16, 2025 20:05 UTC
CAGNONI PABLO JPresident, R&D
GrantPerformance Shares · Derivative 43,846 $0.00 $0.00
Disclosure

SEC source: 0000879169-25-000086 · wk-form4_1752696353.xml · derivative · entry 4

CAGNONI PABLO J · CIK 0001205703 · President, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,846

Underlying: Common Stock · 43,846 shares

Expires 2028-07-15

F4 · derivative.exercise_price: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.

F4 · derivative.exercise_date: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.

Read SEC document
July 15, 2025 Filed Jul 16, 2025 20:05 UTC
CAGNONI PABLO JPresident, R&D
GrantCommon Stock 17,538 $0.00 $0.00
Disclosure

SEC source: 0000879169-25-000086 · wk-form4_1752696353.xml · nonDerivative · entry 3

CAGNONI PABLO J · CIK 0001205703 · President, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 234,800

F2 · shares: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis.

F3 · balance_after: Including the July 15, 2025 grant, this includes an aggregate of 229,661 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.

Read SEC document
July 15, 2025 Filed Jul 16, 2025 20:05 UTC
CAGNONI PABLO JPresident, R&D
Tax withholdingCommon Stock 2,628 $68.25 $179,361.00
Disclosure

SEC source: 0000879169-25-000086 · wk-form4_1752696353.xml · nonDerivative · entry 2

CAGNONI PABLO J · CIK 0001205703 · President, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 217,262

F1 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock.

Read SEC document
July 15, 2025 Filed Jul 16, 2025 20:05 UTC
Stein Steven HEVP & Chief Medical Officer
GrantEmployee Stock Option (right to buy) · Derivative 27,629 $0.00 Strike: $68.25 $0.00
Disclosure

SEC source: 0000879169-25-000085 · wk-form4_1752696308.xml · derivative · entry 6

Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,629

Underlying: Common Stock · 27,629 shares

Expires 2035-07-14

F5 · derivative.exercise_date: The July 15, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.

Read SEC document
July 15, 2025 Filed Jul 16, 2025 20:05 UTC
Stein Steven HEVP & Chief Medical Officer
GrantPerformance Shares · Derivative 30,692 $0.00 $0.00
Disclosure

SEC source: 0000879169-25-000085 · wk-form4_1752696308.xml · derivative · entry 5

Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,692

Underlying: Common Stock · 30,692 shares

Expires 2028-07-15

F4 · derivative.exercise_price: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.

F4 · derivative.exercise_date: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.

Read SEC document
July 15, 2025 Filed Jul 16, 2025 20:05 UTC
Stein Steven HEVP & Chief Medical Officer
GrantCommon Stock 12,277 $0.00 $0.00
Disclosure

SEC source: 0000879169-25-000085 · wk-form4_1752696308.xml · nonDerivative · entry 4

Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 106,592

F2 · shares: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis.

F3 · balance_after: Including the July 15, 2025 grant, this includes an aggregate of 100,327 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested.

Read SEC document
July 15, 2025 Filed Jul 16, 2025 20:05 UTC
Stein Steven HEVP & Chief Medical Officer
Tax withholdingCommon Stock 1,596 $68.25 $108,927.00
Disclosure

SEC source: 0000879169-25-000085 · wk-form4_1752696308.xml · nonDerivative · entry 3

Stein Steven H · CIK 0001673776 · EVP & Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 94,315

F1 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock.

Read SEC document
July 15, 2025 Filed Jul 16, 2025 20:03 UTC
Stamoulis ChristianaEVP & Chief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 24,998 $0.00 Strike: $68.25 $0.00
Disclosure

SEC source: 0000879169-25-000083 · wk-form4_1752696234.xml · derivative · entry 5

Stamoulis Christiana · CIK 0001502917 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,998

Underlying: Common Stock · 24,998 shares

Expires 2035-07-14

F5 · derivative.exercise_date: The July 15, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.

Read SEC document
July 15, 2025 Filed Jul 16, 2025 20:03 UTC
Stamoulis ChristianaEVP & Chief Financial Officer
GrantPerformance Shares · Derivative 27,769 $0.00 $0.00
Disclosure

SEC source: 0000879169-25-000083 · wk-form4_1752696234.xml · derivative · entry 4

Stamoulis Christiana · CIK 0001502917 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,769

Underlying: Common Stock · 27,769 shares

Expires 2028-07-15

F4 · derivative.exercise_price: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.

F4 · derivative.exercise_date: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.

Read SEC document
July 15, 2025 Filed Jul 16, 2025 20:03 UTC
Stamoulis ChristianaEVP & Chief Financial Officer
GrantCommon Stock 11,107 $0.00 $0.00
Disclosure

SEC source: 0000879169-25-000083 · wk-form4_1752696234.xml · nonDerivative · entry 3

Stamoulis Christiana · CIK 0001502917 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,759

F2 · shares: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis.

F3 · balance_after: Including the July 15, 2025 grant, this includes an aggregate of 64,006 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested.

Read SEC document
July 15, 2025 Filed Jul 16, 2025 20:03 UTC
Stamoulis ChristianaEVP & Chief Financial Officer
Tax withholdingCommon Stock 1,445 $68.25 $98,621.25
Disclosure

SEC source: 0000879169-25-000083 · wk-form4_1752696234.xml · nonDerivative · entry 2

Stamoulis Christiana · CIK 0001502917 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,652

F1 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock.

Read SEC document
July 15, 2025 Filed Jul 16, 2025 20:04 UTC
SWAIN PAULA JEVP, Human Resources
GrantEmployee Stock Option (right to buy) · Derivative 14,472 $0.00 Strike: $68.25 $0.00
Disclosure

SEC source: 0000879169-25-000084 · wk-form4_1752696274.xml · derivative · entry 5

SWAIN PAULA J · CIK 0001236934 · EVP, Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,472

Underlying: Common Stock · 14,472 shares

Expires 2035-07-14

F5 · derivative.exercise_date: The July 15, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.

Read SEC document
July 15, 2025 Filed Jul 16, 2025 20:04 UTC
SWAIN PAULA JEVP, Human Resources
GrantPerformance Shares · Derivative 16,077 $0.00 $0.00
Disclosure

SEC source: 0000879169-25-000084 · wk-form4_1752696274.xml · derivative · entry 4

SWAIN PAULA J · CIK 0001236934 · EVP, Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,077

Underlying: Common Stock · 16,077 shares

Expires 2028-07-15

F4 · derivative.exercise_price: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.

F4 · derivative.exercise_date: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.

Read SEC document
July 15, 2025 Filed Jul 16, 2025 20:04 UTC
SWAIN PAULA JEVP, Human Resources
GrantCommon Stock 6,430 $0.00 $0.00
Disclosure

SEC source: 0000879169-25-000084 · wk-form4_1752696274.xml · nonDerivative · entry 3

SWAIN PAULA J · CIK 0001236934 · EVP, Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,482

F2 · shares: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis.

F3 · balance_after: Including the July 15, 2025 grant, this includes an aggregate of 37,390 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.

Read SEC document
July 15, 2025 Filed Jul 16, 2025 20:04 UTC
SWAIN PAULA JEVP, Human Resources
Tax withholdingCommon Stock 563 $68.25 $38,424.75
Disclosure

SEC source: 0000879169-25-000084 · wk-form4_1752696274.xml · nonDerivative · entry 2

SWAIN PAULA J · CIK 0001236934 · EVP, Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,052

F1 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock.

Read SEC document
July 15, 2025 Filed Jul 16, 2025 20:03 UTC
Tray ThomasPrincipal Accounting Officer
GrantEmployee Stock Option (right to buy) · Derivative 3,362 $0.00 Strike: $68.25 $0.00
Disclosure

SEC source: 0000879169-25-000082 · wk-form4_1752696197.xml · derivative · entry 4

Tray Thomas · CIK 0001912317 · Principal Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,362

Underlying: Common Stock · 3,362 shares

Expires 2035-07-14

F4 · derivative.exercise_date: The July 15, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.

Read SEC document
July 15, 2025 Filed Jul 16, 2025 20:03 UTC
Tray ThomasPrincipal Accounting Officer
GrantCommon Stock 4,482 $0.00 $0.00
Disclosure

SEC source: 0000879169-25-000082 · wk-form4_1752696197.xml · nonDerivative · entry 3

Tray Thomas · CIK 0001912317 · Principal Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,313

F2 · shares: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis.

F3 · balance_after: Including the July 15, 2025 grant, this includes an aggregate of 15,166 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.

Read SEC document
July 15, 2025 Filed Jul 16, 2025 20:03 UTC
Tray ThomasPrincipal Accounting Officer
Tax withholdingCommon Stock 583 $68.25 $39,789.75
Disclosure

SEC source: 0000879169-25-000082 · wk-form4_1752696197.xml · nonDerivative · entry 2

Tray Thomas · CIK 0001912317 · Principal Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,831

F1 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units previously reported in Table I as common stock.

Read SEC document
July 15, 2025 Filed Jul 16, 2025 20:02 UTC
Iyengar Vijay KEVP, GMAPPS
GrantEmployee Stock Option (right to buy) · Derivative 14,472 $0.00 Strike: $68.25 $0.00
Disclosure

SEC source: 0000879169-25-000081 · wk-form4_1752696159.xml · derivative · entry 6

Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,472

Underlying: Common Stock · 14,472 shares

Expires 2035-07-14

F5 · derivative.exercise_date: The July 15, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.

Read SEC document
July 15, 2025 Filed Jul 16, 2025 20:02 UTC
Iyengar Vijay KEVP, GMAPPS
GrantPerformance Shares · Derivative 16,077 $0.00 $0.00
Disclosure

SEC source: 0000879169-25-000081 · wk-form4_1752696159.xml · derivative · entry 5

Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,077

Underlying: Common Stock · 16,077 shares

Expires 2028-07-15

F4 · derivative.exercise_price: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.

F4 · derivative.exercise_date: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.

Read SEC document
July 15, 2025 Filed Jul 16, 2025 20:02 UTC
Iyengar Vijay KEVP, GMAPPS
GrantCommon Stock 6,430 $0.00 $0.00
Disclosure

SEC source: 0000879169-25-000081 · wk-form4_1752696159.xml · nonDerivative · entry 4

Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,523

F2 · shares: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis.

F3 · balance_after: Including the July 15, 2025 grant, this includes an aggregate of 37,752 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.

Read SEC document
July 15, 2025 Filed Jul 16, 2025 20:02 UTC
Iyengar Vijay KEVP, GMAPPS
Tax withholdingCommon Stock 836 $68.25 $57,057.00
Disclosure

SEC source: 0000879169-25-000081 · wk-form4_1752696159.xml · nonDerivative · entry 3

Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 35,093

F1 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock.

Read SEC document
July 15, 2025 Filed Jul 16, 2025 20:02 UTC
Iyengar Vijay KEVP, GMAPPS
SaleCommon Stock 1,177 $69.86 $82,225.22
Disclosure

SEC source: 0000879169-25-000081 · wk-form4_1752696159.xml · nonDerivative · entry 2

Iyengar Vijay K · CIK 0001670000 · EVP, GMAPPS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 35,929

Read SEC document
July 15, 2025 Filed Jul 16, 2025 20:02 UTC
Flannelly Barry PEVP & General Manager US
Tax withholdingCommon Stock 1,141 $68.25 $77,873.25
Disclosure

SEC source: 0000879169-25-000080 · wk-form4_1752696123.xml · nonDerivative · entry 3

Flannelly Barry P · CIK 0001615842 · EVP & General Manager US

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,489

F1 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock.

F2 · balance_after: This includes an aggregate of 35,136 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested.

Read SEC document
July 15, 2025 Filed Jul 16, 2025 20:02 UTC
Flannelly Barry PEVP & General Manager US
SaleCommon Stock 1,192 $69.86 $83,273.12
Disclosure

SEC source: 0000879169-25-000080 · wk-form4_1752696123.xml · nonDerivative · entry 2

Flannelly Barry P · CIK 0001615842 · EVP & General Manager US

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 37,630

Read SEC document
July 15, 2025 Filed Jul 16, 2025 20:01 UTC
Hoppenot HerveDirector · Special Advisor to the CEO
Tax withholdingCommon Stock 4,713 $68.25 $321,662.25
Disclosure

SEC source: 0000879169-25-000079 · wk-form4_1752696081.xml · nonDerivative · entry 2

Hoppenot Herve · CIK 0001596492 · Director · Special Advisor to the CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 517,146

F1 · shares: Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock.

F2 · balance_after: This includes an aggregate of 73,486 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested.

Read SEC document
July 15, 2025 Filed Jul 17, 2025 20:04 UTC
Denton Sheila A.EVP & General Counsel
GrantEmployee Stock Option (right to buy) · Derivative 18,419 $0.00 Strike: $68.25 $0.00
Disclosure

SEC source: 0000879169-25-000091 · wk-form4_1752782690.xml · derivative · entry 8

Denton Sheila A. · CIK 0001995298 · EVP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,419

Underlying: Common Stock · 18,419 shares

Expires 2035-07-14

F6 · derivative.exercise_date: The July 15, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.

Read SEC document
July 15, 2025 Filed Jul 17, 2025 20:04 UTC
Denton Sheila A.EVP & General Counsel
GrantPerformance Shares · Derivative 20,461 $0.00 $0.00
Disclosure

SEC source: 0000879169-25-000091 · wk-form4_1752782690.xml · derivative · entry 7

Denton Sheila A. · CIK 0001995298 · EVP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,461

Underlying: Common Stock · 20,461 shares

Expires 2028-07-15

F5 · derivative.exercise_price: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.

F5 · derivative.exercise_date: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.

Read SEC document
July 15, 2025 Filed Jul 17, 2025 20:04 UTC
Denton Sheila A.EVP & General Counsel
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 3,330 $0.00 Strike: $64.25 $0.00
Disclosure

SEC source: 0000879169-25-000091 · wk-form4_1752782690.xml · derivative · entry 6

Denton Sheila A. · CIK 0001995298 · EVP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,993

Underlying: Common Stock · 3,330 shares

Expires 2034-07-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The July 15, 2024 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.

Read SEC document
July 15, 2025 Filed Jul 17, 2025 20:04 UTC
Denton Sheila A.EVP & General Counsel
GrantCommon Stock 8,184 $0.00 $0.00
Disclosure

SEC source: 0000879169-25-000091 · wk-form4_1752782690.xml · nonDerivative · entry 4

Denton Sheila A. · CIK 0001995298 · EVP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,985

F2 · shares: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.